Aegean Pty Ltd

Status: Registered
Australian Company Number: 094844283
Australian Business Number: 80094844283
Registration date: October 23, 2000
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Aegean Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2000-10-23 and was issued with the 094844283 ACN. Its Australian Business Number is 80094844283. Since 2000-11-02, the company is headquartered in VIC, post code 3082. Aegean Pty Ltd was registered for the GST on 2000-10-23, up until 2005-06-29. Aegean Pty Ltd has been using the Aegean Pty Ltd trading name since 2000-11-02 until 2005-05-02 (it should be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 2 trading names. The above data comes from the ABN database which was updated on 2000-11-02.


Details for ABN 80094844283

Type: Australian Private Company

ABN Status

Status From To
Active October 23, 2000 current

Main Name

Name From To
Aegean Pty Ltd November 2, 2000 current

Trading Names

Name From To
Aegean Pty Ltd November 2, 2000 May 2, 2005
Aegean Pty Ltd November 2, 2000 May 2, 2005

Main Location

Location From To
VIC 3082 November 2, 2000 current

Goods & Services Tax (GST)

Status From To
Registered October 23, 2000 June 29, 2005


Find company

VIC 3082 Location

2018 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (, and, ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.